# The Efficiency and Cost‐Effectiveness of 3D‐Printed Patient‐Specific Guide Plate for Patients Undergoing Open‐Wedge High Tibial Osteotomy: A Multicentered Randomized Controlled Trial

**Authors:** Runhua Zhou, Yanjie Guo, Ruixin Wang, Manrong Xu, Qinglin Kang, Yun Shen, Jia Xu, Da Zhong, Shengdi Lu

PMC · DOI: 10.1111/os.70259 · Orthopaedic Surgery · 2026-02-15

## TL;DR

A study found that using 3D-printed guides in knee surgery did not significantly improve pain or cost-effectiveness, though it slightly improved movement and strength.

## Contribution

This is the first multicenter RCT evaluating the clinical and economic impact of 3D-printed patient-specific guide plates in OWHTO.

## Key findings

- 3D-printed guide plates did not significantly improve 12-month WOMAC pain scores compared to conventional methods.
- The guide-plate group showed significantly better knee flexion and 30-s chair-stand performance.
- No cost-effectiveness advantage was observed despite higher device costs in the guide-plate group.

## Abstract

Open‐wedge high tibial osteotomy (OWHTO) is established for young, active patients with medial knee osteoarthritis. Patient‐specific 3D‐printed guide plates have been introduced to improve surgical precision and efficiency, but evidence of clinical and economic benefit is limited. We aimed to determine whether a 3D‐printed patient‐specific guide plate improves efficiency, functional outcomes, and cost‐effectiveness compared to standard OWHTO.

In this multicenter randomized trial, patients scheduled for OWHTO were allocated to either conventional planning (control) or surgery using a patient‐specific 3D‐printed guide plate between November 2020 and June 2024. The primary endpoint was the 12‐month Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score. Secondary outcomes included knee range of motion (flexion in degrees), 30‐s chair‐stand test (number of stands), operative time, and health economic measures (direct costs and quality‐adjusted life years). Analyses were by intention‐to‐treat using appropriate statistical tests.

A total of 180 patients (mean age 55 years, 56.7% male) were randomized equally between groups. At 12 months, mean WOMAC pain was 15.2 (SD 8.4) in the guide‐plate group and 15.6 (SD 8.7) in controls, with no significant difference (p = 0.74). The guide‐plate group showed significantly greater knee flexion (mean 128° vs. 122°; p = 0.04) and a higher 30‐s chair‐stand count (14.2 vs. 12.5 stands; p = 0.02) than controls. There were no other significant between‐group differences in clinical scores. Mean total cost per patient was not statistically significant in the ITT analysis (p = 0.094). Quality‐adjusted life years did not differ between groups, yielding no cost‐effectiveness advantage. These findings echo prior reports that OWHTO techniques with higher costs have similar patient outcomes.

Using a 3D‐printed patient‐specific guide plate did not improve the primary pain outcome or overall functional outcome compared to standard OWHTO. It yielded minor gains in knee flexion and chair‐stand performance, but at greater cost. No overall cost‐effectiveness benefit was observed. Routine use of this technology for OWHTO is not supported by our findings.

Level I, randomized controlled trial.

Chinese Clinical Trial Registry (https://www.chictr.org.cn/): ChiCTR2000038619

In a multicenter randomized trial of open‐wedge high tibial osteotomy, use of a 3D‐printed patient‐specific guide plate noted no adjusted difference in 12‐month WOMAC pain; small gains in ROM/chair‐stand; higher device cost; no QALY gain; no overall cost‐effectiveness.

## Full-text entities

- **Genes:** KL (klotho) [NCBI Gene 9365] {aka HFTC3, KLA}
- **Diseases:** valgus overcorrection (MESH:D060906), nonunion (MESH:C538144), pathology (MESH:D005598), infection (MESH:D007239), knee osteoarthritis (MESH:D020370), WBL (MESH:D015431), multi-compartment disease (MESH:D003161), osteoporosis (MESH:D010024), tibial fractures (MESH:D013978), MCID (MESH:D000076263), inflammatory arthritis (MESH:D001168), knee disorders (MESH:D007718), rheumatoid arthritis (MESH:D001172), stiffness (MESH:C566112), varus alignment (MESH:D060905), death (MESH:D003643), hip fracture (MESH:D006620), MCL (MESH:C535516), II (MESH:C537730), neurologic (MESH:D009461), III medial compartment OA (MESH:D010003), flexion contracture (MESH:D003286), lateral or patellofemoral compartment degeneration (MESH:D046788), varus malalignment (MESH:D017760), functional disability (MESH:D003291), COPD (MESH:D029424), OWHTO (MESH:C537350), muscle strain (MESH:D013180), psychiatric condition (MESH:D001523), vascular disease (MESH:D014652), swelling (MESH:D004487), (waist) fracture (MESH:D064250), anxiety (MESH:D001007), HTO (MESH:D020429), pain (MESH:D010146), fracture (MESH:D050723)
- **Chemicals:** alcohol (MESH:D000438), CNY (-)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12967555/full.md

## Figures

1 figure with captions in the complete paper: https://tomesphere.com/paper/PMC12967555/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12967555/full.md

---
Source: https://tomesphere.com/paper/PMC12967555